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Objectives: Quality	 of	 life	 (QoL)	 after	 intracerebral	 hemorrhage	 (ICH)	 is	 poorly	
known.	This	study	investigated	factors	affecting	QoL	and	depression	after	spontane‐
ous	ICH.










3–5	 at	 3	months	 59.4%	 versus	 44.4%	 (p	=	0.030).	 Predictors	 for	 lower	HRQoL	 by	
both	scales	were	higher	NIHSS	with	OR	1.28	(95%	CI	1.13–1.46)	for	EQ‐5D‐5L,	and	
OR	1.28	 (1.15–1.44)	 for	15D,	older	 age	 (OR	1.10	 [1.03–1.16],	 and	OR	1.09	 [1.03–







by	 stroke	 severity,	 comorbidities	 and	 age.	 Feelings	 of	 depression	 before	 ICH	 had	
stronger	influence	on	reporting	depression/anxiety	after	ICH	than	stroke	severity‐
related	and	outcome	parameters.	Thus,	simple	questions	on	patient's	premorbid	feel‐
ings of sadness/depression could be used to identify patients at risk of depression 
after	ICH	for	focusing	follow‐up	and	treatment.
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1  | INTRODUC TION
Intracerebral	 hemorrhage	 (ICH)	 is	 the	 second	most	 common	 type	
of	stroke	(van	Asch	et	al.,	2010).	As	many	as	40.4%	of	the	patients	




have been shown to have less favorable outcome compared to isch‐




















et	 al.,	 2016).	 Another	 study	 reported	 baseline	 National	 Institutes	
of	Health	Stroke	Scale	 (NIHSS)	≥14	versus	<14	 to	have	 the	 stron‐
gest	 association	with	poor	HRQoL	3	months	after	 ICH.	Also	older	
age,	 use	 of	 antithrombotics,	 larger	 and	 deep	 ICH,	 intraventricular	
hemorrhage	 (IVH),	early	worsening	of	 the	neurological	deficit,	and	
completion	of	the	questionnaire	by	proxy	responder	associated	with	
worse	HRQoL	 (Christensen	 et	 al.,	 2009;	 Faught	 et	al.,	 1989;	 Lahti	
et	al.,	 2017).	Hence,	 these	 parameters	 are	 associated	mostly	with	
the	severity	of	the	index	ICH.
Post‐ICH	depression	has	been	shown	to	have	a	negative	impact	
on	 outcome	 unrelated	 to	 initial	 hemorrhage	 severity	 (Stern‐Nezer	




&	 Brogger,	 2012;	 Puumalainen,	 Numminen,	 Elonheimo,	 Roine,	 &	
Sintonen,	2016;	Sintonen,	2001).	EQ‐5D‐5L	and	15D	define	health	
in	five	(EQ‐5D‐5L),	and	15	(15D)	dimensions,	including	motor	as	well	
as	mental	 functioning.	 In	 earlier	 studies,	many	 of	 the	 factors	 that	
associate	with	worse	HRQoL	are	also	predictors	of	worse	functional	






2  | MATERIAL S AND METHODS
This study is part of a prospective study on genetic and environmen‐
tal	risk	factors	of	ICH.	We	aimed	to	recruit	all	consecutive	patients	





To	 participate,	 the	 patient	 or	 his/her	 proxy	 had	 to	 give	 an	 in‐
formed	signed	consent.	If	the	patient	was	unable	to	write,	the	con‐
sent could be given orally in the presence of a witness unrelated to 
the	 study.	We	used	structured	questionnaires	on	profession,	 feel‐
ings	of	depression,	smoking,	and	alcohol	consumption	before	 ICH.	









perpendicular measures of the hematoma on CT images.
Living	 and	 working	 status,	 modified	 Rankin	 Scale	 (mRS),	 and	
Barthel	Index	(BI)	were	evaluated	at	3	months	(±1	week)	after	ICH	
by a combination of revisiting the electronic medical charts and tele‐
phone	interview	(HS).	The	patients	were	interviewed	via	telephone,	
or	 alternatively,	 if	 the	 corresponding	 information	 on	 the	 outcome	
parameters	were	recorded	in	their	electronic	medical	charts,	these	
were	collected.	 If	 the	patient	was	reached	 later,	he/she	was	asked	
to	 recall	 the	 situation	at	3	months.	As	 the	medical	 files	 in	Finland	










lated using population‐based preference weights. One represents 
perfect	 health,	 0	death,	 and	negative	 values	health	 states	 consid‐
ered	 worse	 than	 death.	 As	 there	 was	 no	 population‐based	 utility	
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TA B L E  1  Comparison	of	the	patients	with	low	and	high	EQ‐5D‐5L	utility	index	(n = 117)a 
Variable Low (≤0.590) n = 59 High (>0.590) n = 58 p value
Age,	y 70.0	(62.0–80.0) 70.5	(61.8–75.0) 0.195
Male 29	(49.2) 32	(55.2) 0.515
Agreement	by	proxy 25	(42.4) 8 (13.8) 0.001
mRS	3–5	prior	to	ICH 4	(6.8) 0 (0.0) 0.119
Diabetes 9	(15.3) 7 (12.1) 0.616
History	of	ischemic	stroke 9	(15.3) 6 (10.3) 0.427
History	of	any	ICH 5	(8.5) 2	(3.4) 0.439
COPD/asthma 9	(15.3) 2	(3.4) 0.029
Dementia 3	(5.1) 1 (1.7) 0.619
Coronary artery disease 9	(15.3) 3	(5.2) 0.072
Atrial	fibrillation 15	(25.4) 14	(24.1) 0.872
Chronic heart failure 7 (11.9) 1 (1.7) 0.061
History	of	cancer 9	(15.3) 18 (31.0) 0.043
Antiplatelet	treatment 13 (22.0) 10 (17.2) 0.514
Anticoagulant	treatment 13 (22.0) 12 (20.7) 0.859
Antihypertensive	medication 32	(54.2) 29	(50.0) 0.646
Antidepressant	medication 3	(5.1) 0 (0.0) 0.244
Sad	or	depressed	for	more	than	2	weeks	during	the	
year	prior	to	ICHb 
14	(30.4) 6 (11.1) 0.160
Any	alcohol	use	within	1	year	prior	to	ICHb  49	(86.0) 45	(78.9) 0.325
No or little stress at homeb  39 (72.2) 47	(90.4) 0.017
Living	alone 24	(40.7) 14	(24.1) 0.056
Married	or	registered	relationshipb  32	(56.1) 36 (63.2) 0.445
Occupational	status,	working 10 (16.9) 14	(24.1) 0.336
High	education	(Master	or	Bachelor's	degree)b  10 (17.9) 20	(35.1) 0.038
NIHSS	on	admission 10.0	(3.0–15.0) 4.0	(2.0–6.0) <0.001
GCS	on	admission 15.0	(13.0–15.0) 15.0	(14.0–15.0) <0.001
Baseline	ICH	volume,	mL 10.9	(4.5–23.0) 7.2	(1.9–16.2) 0.037
ICH	location   0.001
ICH	location,	lobar 8 (13.6) 24	(41.4)  
ICH	location,	deep	supratentorial 48	(81.4) 30	(51.7)  
ICH	location,	infratentorial 3	(5.1) 4	(6.9)  
Deterioration	(increase	in	NIHSS	at	least	4	points)	
within	1	week	of	ICH
5	(8.5) 1 (1.7) 0.207
Acute	myocardial	infarction	or	heart	failure	within	
1	week	of	ICH
2	(3.4) 0 (0.0) 0.496
Any	neurosurgery 4	(6.8) 1 (1.7) 0.364
DNR orders in hospital 12 (20.3) 3	(5.2) 0.014
mRS	at	3	months   <0.001
mRS	0 0 (0.0) 5	(8.6)  
mRS	1 2	(3.4) 11 (19.0)  
mRS	2 16 (27.1) 34	(58.6)  
mRS	3 15	(25.4) 5	(8.6)  
mRS	4 16 (27.1) 3	(5.2)  
mRS	5 10 (16.9) 0 (0.0)  
Barthel	index	at	3	months 90.0	(55.0–100.0) 100.0	(100.0–100.0) <0.001
(Continues)
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Excretion,	Usual	activities,	Mental	function,	Discomfort	and	symp‐




using a set of population‐based utility weights.
The	 patients	 were	 divided	 into	 two	 utility	 index	 groups	 using	
the	median	utility	indexes	(low	or	high).	For	EQ‐5D‐5L,	the	HRQoL	
was	 considered	 low,	 if	 the	 index	 was	 ≤0.590	 (median),	 and	 high,	
if	 the	 index	was	>0.590,	 and	 for	 15D	≤0.817	 and	>0.817,	 accord‐
ingly.	For	 the	EQ‐5D‐5L	depression/anxiety	question,	 the	patients	
were divided into two groups: reporting symptoms of depression/
anxiety	or	not.	We	compared	the	baseline	and	outcome	character‐
istics between each two groups using univariate regression analysis. 
Variables with p	<	0.2	in	the	univariate	regression	model	were	cho‐
sen	 for	 the	multivariable	binary	 regression	model	 for	HRQoL,	and	
variables with p	<	0.1	for	depression/anxiety.	For	the	multivariable	
models	 on	 EQ‐5D‐5L	 and	 15D	 utility	 indexes,	 we	 tested	 associ‐
ations	of	baseline	 characteristics	with	 the	quality	of	 life,	 and	 thus	
the outcome parameters were not included in the analyses. We also 
compared the characteristics of the patient groups with and without 
(missing)	data	on	quality	of	life	to	test	for	selection	bias.
Statistical	 analyses	were	made	using	SPSS	v.24	 (IBM,	Armonk,	
NY);	 the	 multivariable	 analysis	 for	 depression/anxiety	 was	 made	
using R Package “brglm” to be able to handle the situation with no 
cases	in	one	group;	for	QoL	index	values	we	used	logistic	regression	
analysis	 (Forward	 LR).	We	 express	 categorical	 variables	 as	 counts	
(%),	continuous	variables	with	normal	distribution	as	mean	(SE),	and	
continuous variables not normally distributed as median (IQR) val‐
ues. The differences between the groups were calculated using the 
χ2	test,	the	t	test,	or	the	Mann–Whitney	U test as appropriate.
This study has been approved by the institutional review 
board	 and	 local	 ethical	 committee	 of	Helsinki	 University	Hospital	
(11.12.2013	311/13103/01/2013	and	12.10.2016	HUS/1662/2016).
3  | RESULTS






at	3	months	was	20.2%	 (56	patients),	 and	one	 foreign	patient	was	









and	were	 less	 likely	 to	 live	 at	 home	 (54.7%	 vs.	 77.4%;	 p	<	0.001).	











high	 (>0.590)	 EQ‐5D‐5L	 utility	 indexes.	 Lower	 HRQoL	 associated	
with	consent	given	by	patient's	proxy,	history	of	COPD	or	asthma,	
frequently	 felt	 home‐related	 stress,	 lower	 education	 level,	 higher	
NIHSS	 and	 lower	 GCS	 scores	 on	 admission,	 higher	 baseline	 ICH	
volumes,	deep	 ICH	 location,	and	DNR	orders	during	hospital	 stay.	
Patients	with	lower	HRQoL	had	lower	BI,	higher	mRS,	and	were	less	
likely to live at home at 3 months and 1 year. Patients with better 
HRQoL	 had	 more	 likely	 had	 cancer,	 including	 curatively	 treated	
forms.







Variable Low (≤0.590) n = 59 High (>0.590) n = 58 p value
Living	at	home	at	3	months 36 (61.0) 55	(94.8) <0.001
Working at 3 months 2	(3.4) 2	(3.4) 1.000





The bold values indicates P	<	0.05.	
TA B L E  1   (Continued)
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TA B L E  2  Comparison	of	the	patients	with	low	and	high	15D	score	(n = 108)a 
Variable Low (≤0.817) n = 54 High (>0.817) n = 54 p value
Age,	y 72.0	(62.8–80.0) 68.0	(60.5–75.0) 0.035
Male 29	(53.7) 31	(57.4) 0.699
Agreement	by	proxy 27	(50.0) 6 (11.1) <0.001
mRS	3–5	prior	to	ICH 2 (3.7) 0 (0.0) 0.495
Diabetes 9 (16.7) 7 (13.0) 0.588
History	of	ischemic	stroke 8	(14.8) 7 (13.0) 0.781
History	of	any	ICH 6 (11.1) 1 (1.9) 0.113
COPD or asthma 6 (11.1) 2 (3.7) 0.270
Dementia 3	(5.6) 0 (0.0) 0.243
Coronary artery disease 6 (11.1) 3	(5.6) 0.489
Atrial	fibrillation 16 (29.6) 11	(20.4) 0.267
Chronic heart failure 6 (11.1) 1 (1.9) 0.113
History	of	cancer 10	(18.5) 14	(25.9) 0.355
Antiplatelet	treatment 11	(20.4) 10	(18.5) 0.808
Anticoagulant	treatment 14	(25.9) 9 (16.7) 0.240
Antihypertensive	medication 34	(63.0) 23	(42.6) 0.034
Antidepressant	medication 3	(5.6) 0 (0.0) 0.243
Sad	or	depressed	for	more	than	2	weeks	during	 
the	year	prior	to	ICHb 
8 (19.0) 10 (19.6) 0.946
Any	alcohol	use	(within	1	year	prior	ICH)b  44	(84.6) 41	(77.4) 0.344
No or little stress at homeb  37	(75.5) 43	(84.3) 0.271
Living	alone 20 (37.0) 11	(20.4) 0.056
Married	or	registered	relationshipb  31	(59.6) 38	(70.4) 0.246
Occupational	status,	working 9 (16.7) 15	(27.8) 0.165
High	education	(Master	or	Bachelor's	 
degree)b 
9 (17.6) 22	(41.5) 0.008
NIHSS	on	admission 9.0	(3.8–15.5) 3.0	(2.0–5.0) <0.001
GCS	on	admission 14.5	(13.0–15.0) 15.0	(15.0–15.0) <0.001
Baseline	ICH	volume,	mL 13.6	(6.2–24.5) 4.5	(1.7–16.0) 0.002
ICH	location   0.202
ICH	location,	lobar 11	(20.4) 20 (37.0)  
ICH	location,	deep	supratentorial 39 (72.2) 31	(57.4)  
ICH	location,	infratentorial 4	(7.4) 3	(5.6)  
Any	neurosurgery 5	(9.3) 0 (0.0) 0.057
DNR orders in hospital 14	(25.9) 2 (3.7) 0.001
Deterioration	(increase	in	NIHSS	at	least	 
4	points)	within	1	week	of	ICH
5	(9.3) 1 (1.9) 0.205
Acute	myocardial	infarction	or	heart	failure	within	
1	week	of	ICH
2 (3.7) 0 (0.0) 0.495
mRS	at	3	months   <0.001
mRS	0 0 (0.0) 4	(7.4)  
mRS	1 2 (3.7) 11	(20.4)  
mRS	2 14	(25.9) 33 (61.1)  
mRS	3 15	(27.8) 4	(7.4)  
mRS	4 13	(24.1) 2 (3.7)  
mRS	5 10	(18.5) 0 (0.0)  
(Continues)
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sion	 analysis,	Nagelkerke	R	Square	was	0.493,	 indicating,	 that	 the	
model	included	approximately	50%	of	factors	influencing	EQ‐5D‐5L	
utility	 index	 value,	 and	 Hosmer	 and	 Lemeshow	 Goodness	 of	 Fit	




after	 ICH	 were	 more	 common	 among	 patients	 with	 mRS	 3–5	 at	
3	months	 after	 ICH,	 patients	 with	 dementia	 before	 ICH,	 patients	
with	 DNR	 orders	 during	 hospital	 stay,	 and	 patients	 having	 been	
feeling	sad	or	depressed	during	the	year	prior	to	ICH.	However,	 in	











ies	 also	 imply	 (Chung	 &	 Han,	 2017;	 Iqbal,	 Francis,	 Reid,	Murray,	
&	Denvir,	 2010).	As	 the	 consent	 given	 by	 proxy—the	 patient	 not	
being	able	to	consent	him/herself—indicates	more	severe	stroke,	it	
Variable Low (≤0.817) n = 54 High (>0.817) n = 54 p value
Barthel	Index	at	3	months 92.5	(53.8–100.0) 100	(100.0–100.0) <0.001
Living	at	home	at	3	months 33 (61.1) 52	(96.3) <0.001
Working at 3 months 1 (1.9) 3	(5.6) 0.618






The bold values indicates P	<	0.05.		
TA B L E  2   (Continued)
Variable OR (95% CI) p value
Predictor	for	decreased	EQ‐5D‐5L	utility	indexb    







Predictor	for	decreased	15D	utility	indexc    











TA B L E  3  Multivariable	binary	logistic	
regression analysis for predictors of 
decreased	a)	EQ‐5D‐5L	utility	index,	and	
b)	15D	score	at	3	monthsa 
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TA B L E  4  Comparison	of	the	patients	with	reported	depression	and/or	anxiety	in	EQ‐5D‐5L	3	months	after	ICH	(n = 122)a 
Variable Not depressed n = 68 Depressed n = 54 p value
Age,	y 69.5	(62.3–75.8) 72.5	(59.8–79.3) 0.335
Male 34	(50.0) 30	(55.6) 0.542
Agreement	by	proxy 18	(26.5) 18 (33.3) 0.409
mRS	3–5	prior	to	ICH 1	(1.5) 3	(5.6) 0.321
Diabetes 10	(14.7) 6 (11.1) 0.559
History	of	ischemic	stroke 8 (11.8) 7 (13.0) 0.841
History	of	any	ICH 2 (2.9) 5	(9.3) 0.239
COPD or asthma 4	(5.9) 7 (13.0) 0.212
Dementia 0 (0.0) 5	(9.3) 0.015
Coronary artery disease 4	(5.9) 8	(14.8) 0.100
History	of	atrial	fibrillation 15	(22.1) 16 (29.6) 0.340
Chronic heart failure 3	(4.4) 5	(9.3) 0.464
History	of	cancer 15	(22.1) 13	(24.1) 0.793
Antiplatelet	treatment 15	(22.1) 10	(18.5) 0.630
Anticoagulant	treatment 11 (16.2) 15	(27.8) 0.120
Antihypertensive	medication 35	(51.5) 29	(53.7) 0.806
Antidepressant	medication 2 (2.9) 1 (1.9) 1.000
Sad	or	depressed	for	more	than	2	weeks	
during	the	year	prior	to	ICHb 
6 (10.0) 15	(33.3) 0.003
Alcohol	use	(within	1	year	prior	to	ICH)b  55	(83.3) 43	(81.1) 0.754
No or little stress at homeb  53	(86.9) 37	(74.0) 0.085
Living	alone 23 (33.8) 16 (29.6) 0.622
Married	or	registered	relationshipb  40	(59.7) 33	(63.5) 0.676
Occupational	status,	working 13 (19.1) 13	(24.1) 0.507
High	education	(Master	or	Bahelor's	degree)b  21 (31.8) 10 (19.2) 0.123
NIHSS	on	admission 5	(2.3–9.8) 6	(2.0–13.3) 0.262
GCS	on	admission 15	(14.0–15.0) 15	(13.8–15.0) 0.683
Baseline	ICH	volume,	mL 8.0	(1.9–16.4) 12.0	(4.0–21.9) 0.082
ICH	location   0.555
ICH	location,	lobar 22	(32.4) 13	(24.1)  
ICH	location,	deep	supratentorial 42	(61.8) 38	(70.4)  
ICH	location,	infratentorial 4	(5.9) 3	(5.6)  
ICH	evacuation/any	neurosurgery 1	(1.5) 4	(7.4) 0.169
DNR orders in hospital 4	(5.9) 12 (22.2) 0.008
Deterioration	(increase	in	NIHSS	at	least	4	
points)	within	1	week	of	ICH
5	(7.4) 2 (3.7) 0.462
Acute	myocardial	infarction	or	heart	failure	
within	1	week	of	ICH
0 (0.0) 2 (3.7) 0.194
mRS	at	3	months   0.175
mRS	0 4	(5.9) 1 (1.9)  
mRS	1 10	(14.7) 3	(5.6)  
mRS	2 31	(45.6) 20 (37.0)  
mRS	3 10	(14.7) 12 (22.2)  
mRS	4 8 (11.8) 13	(24.1)  
mRS	5 5	(7.4) 5	(9.3)  
mRS	3–5	at	3	months 23 (33.8) 30	(55.6) 0.016
(Continues)
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is	not	surprising	that	it	associates	with	worse	HRQoL.	As	also	seen	
in	 general	 population,	QoL	 has	 an	 inverse	 association	with	 older	
age	(Self‐Reported	Population	Health:	An	International	Perspective	
based	on	EQ‐5D,2014).	Measured	by	EQ‐5D‐5L,	patients	with	his‐
tory	of	cancer	 reported	better	HRQoL.	This	 is	 likely	 to	be	biased	





depression and premorbid psychosocial stress were associated with 
depression	at	3	months	 (Kreiter	et	al.,	2013).	Depression	 is	known	
to	be	common	among	dementia	patients	(Meyers,	1998),	and	in	our	
study,	 all	 patients	 with	 dementia	 reported	 feelings	 of	 depression	
and/or	anxiety	after	ICH.	However,	few	patients	had	dementia,	and	
dementia had no statistically significant association with depres‐









Since	depression	after	 ICH	has	been	 shown	 to	have	a	nega‐
tive impact on outcome unrelated to initial hemorrhage severity 
(Stern‐Nezer	et	al.,	2017),	 it	would	be	 important	 to	find	the	pa‐
tients	at	risk	of	depression	after	 ICH,	and	focus	close	follow‐up	
for depression on them. Our study implies that premorbid feel‐
ings of depression during the past year is a risk for depression 
and/or	anxiety	after	stroke,	and	using	simple	questions,	it	would	
be	 possible	 to	 identify	 such	 patients	 at	 risk.	Obviously,	 for	 the	
diagnosis	 of	 depression,	 further	 evaluation	 is	 needed.	 The	 low	
number	of	 depression	diagnoses	prior	 to	 ICH	made	 this	 comor‐
bidity	 less	 sensitive	 in	 identifying	 patients	 at	 risk	 for	 post‐ICH	
depression.
The	 strength	 of	 our	 study	 is	 having	 extensive	 data	 on	 comor‐
bidities	and	questioning	feelings	of	depression.	The	cohort	is	homo‐
geneous,	 as	 the	majority	of	 the	patients	are	ethnic	Finns,	 and	 the	
utility	index	values	for	the	HRQoL	have	country‐specific	values.	In	
addition,	we	used	two	different	methods	for	the	HRQoL	evaluation.
The limitations of the study include the rather small cohort and 
the amount of missing data. The reasons for no consent include 
death,	early	transport	to	another	hospital,	aphasia	and	no	proxy,	and	





Variable Not depressed n = 68 Depressed n = 54 p value
Barthel	Index	at	3	months 100	(91.3–100.0) 97.5	(80.0–100.0) 0.164
EQ−5D−5L	utility	index	at	3	monthsb  0.711	(0.577–1.000) 0.517	(0.341–0.588) <0.001
15D	score	at	3	monthsb  0.885	(0.769–0.941) 0.770	(0.588–0.827) <0.001
Living	at	home	at	3	months 54	(79.4) 42	(77.8) 0.827
Working at 3 months 2 (2.9) 2 (3.7) 1.000






The bold values indicate P	<	0.05.
TA B L E  4   (Continued)










a102 patients included in analysis due to missing data.
The bold value indicates P	<	0.05.	
TA B L E  5  Multivariable	binary	logistic	
regression analysis for associations with 
depression/anxiety	in	EQ‐5D‐5L	at	
3 months (n = 122)a 
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individual	level,	it	is	not	surprising,	that	the	models	generated	were	
able	 to	 explain	 only	 50%	of	HRQoL.	As	 the	 past	 feelings	 prior	 to	
index‐ICH	 are	 questioned,	 it	 cannot	 be	 excluded,	 that	 depressive	
feelings	at	the	time	of	evaluation	affect	the	results,	even	though	the	
patients	are	asked	 to	 recall	 the	situation	before	 ICH.	The	patients	
were	sent	the	QoL	questionnaires	at	3	months,	and	even	though	the	
exact	time	point	was	not	recorded,	the	analysis	represents	situation	
















ity‐related and outcome parameters. Our study suggests that a 
questionnaire	on	premorbid	 self‐reported	 sadness	or	depression	
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